Laidlaw Wealth Management’s Dow Inc DOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-5,307
Closed -$213K – 75
2024
Q4
$213K Sell
5,307
-2,651
-33% -$124K 0.09% 163
2024
Q3
$435K Sell
7,958
-472
-6% -$24.9K 0.22% 118
2024
Q2
$447K Buy
8,430
+540
+7% +$30.9K 0.25% 114
2024
Q1
$457K Sell
7,890
-599
-7% -$33.1K 0.26% 112
2023
Q4
$466K Sell
8,489
-1,376
-14% -$70.3K 0.17% 136
2023
Q3
$509K Sell
9,865
-9,760
-50% -$524K 0.17% 139
2023
Q2
$1.05M Sell
19,625
-229
-1% -$12.2K 0.2% 118
2023
Q1
$1.09M Buy
19,854
+1,537
+8% +$86.5K 0.22% 115
2022
Q4
$923K Buy
18,317
+84
+0.5% +$4.1K 0.2% 128
2022
Q3
$801K Sell
18,233
-3,881
-18% -$197K 0.19% 131
2022
Q2
$1.14M Buy
22,114
+642
+3% +$41.1K 0.23% 116
2022
Q1
$1.37M Buy
21,472
+4,627
+27% +$279K 0.23% 111
2021
Q4
$955K Buy
+16,845
New +$960K 0.15% 147
2021
Q1
– Sell
-7,403
Closed -$411K – 254
2020
Q4
$411K Buy
7,403
+2,623
+55% +$135K 0.09% 219
2020
Q3
$225K Buy
+4,780
New +$215K 0.1% 184
2020
Q1
– Sell
-3,737
Closed -$205K – 157
2019
Q4
$205K Buy
+3,737
New +$193K 0.13% 160

Other funds holding DOW

Laidlaw Wealth Management's DOW Position: Q1 2025 in Review

Laidlaw Wealth Management sold out of Dow Inc (DOW) in Q1 2025, closing a stake of 5,307 shares — an estimated $213K sold.

Laidlaw Wealth Management first reported a position in DOW in Q4 2019 and held it in 16 quarters. The position peaked at $1.37M in Q1 2022. 1,347 funds tracked by Wall St. Rank hold DOW as of Q1 2025.

  • Laidlaw Wealth Management reported no remaining Dow Inc position as of Q1 2025 after selling out during the quarter.
  • Laidlaw Wealth Management sold 5,307 Dow Inc shares in Q1 2025, an estimated $213K.
  • Laidlaw Wealth Management first reported a position in Dow Inc in Q4 2019 and held it in 16 quarters.
  • Laidlaw Wealth Management's Dow Inc position peaked at $1.37M in Q1 2022.
  • 1,347 funds tracked by Wall St. Rank held Dow Inc as of Q1 2025.

Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.